Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|November 26, 2025
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomasMaxwell T Laws, Dhruval Bhatt, Debjani Mandal, et al.
Research Square|October 27, 2023
An ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndromeAllison Snyder, Veronica H Ryan, James Hawrot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2026
Herpesvirus genome integration in whole-genome sequences of dementia and control cohortsStacey L Piotrowski, Mary Alice Allnutt, Kory Johnson, et al.
Cell Death & Disease|April 15, 2026
PRMT5 inhibition impairs Fanconi Anemia pathway-mediated homologous recombination and enhances the antitumor efficacy of Temozolomide in glioblastomaShumpei Onishi, Sridharan Jayamohan, Ashis Chowdhury, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2026
Extracellular vesicles from wild-type Epstein-Barr virus-transformed B-cells export host DNA and EBV EBER1Michelle L Pleet, Rose Peterson, Stephanie Chidester, et al.
The Journal of Clinical Investigation|July 3, 2023
Human endogenous retrovirus K contributes to a stem cell niche in glioblastomaAshish H Shah, Sarah R Rivas, Tara T Doucet-O'Hare, et al.
American Journal of Human Genetics|June 13, 2009
Mutations in a BTB-Kelch protein, KLHL7, cause autosomal-dominant retinitis pigmentosaJames S Friedman, Joseph W Ray, Naushin Waseem, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastomaDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.
The Journal of Clinical Investigation|March 17, 2025
Activating antiviral immune responses potentiates immune checkpoint inhibition in glioblastoma modelsDeepa Seetharam, Jay Chandar, Christian K Ramsoomair, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2026
A class of deep intronic IGHMBP2 variants activate a shared cryptic splice donor, enabling correction of select variants with a single antisense oligonucleotideSarah Silverstein, Andrew D Nguyen, Rotem Orbach, et al.
Pageof 7